Effect of Hypocaloric Diet and Exercise in Obese Women Who Are Subjected to IVF Cycle

The purpose of this study is to determine the impact of diet and physical exercise program on pregnancy rate and live birth in obese women who undergo an IVF cycle.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The objective of this study is showing that obesity significantly affects the in vitro fertilization cycles lowering the reproductive capacity. The study is been performed in Hospital de la Santa Creu i Sant Pau and Fundació Puigvert of Barcelona. Patients recluted are obese women with sterility problems that require in vitro fertilization (IVF) with a body mass index BMI between 30-35. It´s a randomised study in which half of the patients undergo to a 6 weeks program of diet and exercice. We will analyse the response to ovaric stimulation, the results of the egg retrieval (ovocyte number and quality), rates of fecundation, embryo implantation and clinical gestation.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08025
        • Hospital de la Santa Creu i Sant Pau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women who want pregnancy.
  • Basal FSH levels ≤ 10 IU / l.
  • Infertility to justify treatment with IVF/ICSI.
  • Being included in a long protocol with GnRH agonist.
  • Presence of both ovaries and uterus able to support embryo implantation and pregnancy.
  • Body mass index (BMI) ≥ 30 kg/m2 and ≤ 35 kg/m2.
  • Absence of pregnancy before starting ovarian stimulation.
  • Having given their written consent.

Exclusion Criteria:

  • Female age ≤ 18 years and ≥ 35 years.
  • Severe male factor not permit an IVF-ICSI with ejaculated sample.
  • Patients with low ovarian reserve (basal FSH levels ≥ 10 IU / l or lower antral follicle count to 6 follicles in both ovaries).
  • HIV seropositivity, HBV or HCV.
  • Clinically important disease.
  • Having frozen embryos from previous cycles of assisted reproduction.
  • Unexplained vaginal bleeding.
  • Poor response in previous IVF cycles with standard stimulation protocols
  • Any contraindication to become pregnant.
  • Known allergy to preparations of gonadotropins or its excipients.
  • High consumption of alcohol, drugs or psychotropic drugs.
  • Concurrent participation in another study.
  • Patients who have done previous cycles of IVF / ICSI without success

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Diet and exercise
Total caloric intake aimed at maintaining a diet with> 50% of the caloric content in the form of carbohydrates, less than 10% in the form of saturated fats and 20% from monounsaturated / polyunsaturated (if applicable, up to 25% fat monounsaturated), less than 300 mg / day of dietary cholesterol and about 1.0 g of protein / kg ideal body weight / day. 3 sessions per week on a bicycle ergometer or on a treadmill (according to body fat distribution and other parameters) modifications carried out weekly, with a gradual increase as to exercise until maximal oxygen consumption 60 - 70% would always preceded by heating 5 minutes.
Total caloric intake aimed at maintaining a diet with> 50% of the caloric content in the form of carbohydrates, less than 10% in the form of saturated fats and 20% from monounsaturated / polyunsaturated (if applicable, up to 25% fat monounsaturated), less than 300 mg / day of dietary cholesterol and about 1.0 g of protein / kg ideal body weight / day.
No Intervention: No intervention
Usual diet and exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pregnancy rate
Time Frame: 14 days after embryo transfer
Pregnancy rate by cycle
14 days after embryo transfer

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hyperstimulation rate
Time Frame: At luteal phase and first weeks of pregnancy
Number of patients with moderate or severe hyperstimulation
At luteal phase and first weeks of pregnancy
Fertility rate
Time Frame: 24 hours post pick up
Rate of mature oocytes fertilized by conventional IVF or ICSI
24 hours post pick up
Mature oocytes
Time Frame: Pick up day
Number of total mature oocytes obtained after stimulation
Pick up day
Cancellation rate
Time Frame: Durinf the stimulation in follicular phase
Stimulated Patients who fail to perform the follicular puncture
Durinf the stimulation in follicular phase
Good quality embryos
Time Frame: Day 3 to 5 post pick up
Number of good quality embryos obtained (A and B) by patient
Day 3 to 5 post pick up
Abortion rate
Time Frame: First trimester of pregnancy
Number of non evolutive pregnancies during the first trimester
First trimester of pregnancy
Live birth rate
Time Frame: Between 7 a 9 months after treatment
Amount of patients who finish the treatment with a live newborn
Between 7 a 9 months after treatment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leptin, adiponectin, resistin, interleukin VI, TNF-α, visfatin, IGF1 and PAI I
Time Frame: During the stimulation phase
Study the relationship between obesity and measurable surrogate parameters the same as the products of secretion of fat (leptin, adiponectin, resistin, interleukin VI, TNF-α, visfatin, IGF1 and PAI I) or with inflammatory parameters results of an IVF cycle.
During the stimulation phase

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juan José Espinós-Gómez, MD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

September 23, 2013

First Submitted That Met QC Criteria

September 25, 2013

First Posted (Estimate)

September 30, 2013

Study Record Updates

Last Update Posted (Actual)

August 22, 2017

Last Update Submitted That Met QC Criteria

August 21, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IIBSP-DHE-2011-42

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Diet and exercise

Subscribe